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COMMUNITY RESEARCH AND ACTION 
 
Usability Evaluation of Diabetes MAP: An Internet-delivered Diabetes Medication Adherence 
Promotion Intervention 
 
Magaela C. Bethune 
 
Thesis under the direction of Professor William L. Turner 
Usability testing ensures users are able to effectively, efficiently, and satisfactorily interact 
with a website. We evaluated the usability of an Internet-delivered health promotion intervention 
called Diabetes MAP. 
We recruited adult T2DM patients (N=32) prescribed diabetes oral agents or insulin and 
receiving care at an academic medical center. Participants completed an enrollment survey to 
collect demographic information. Medical records were reviewed to collect medication and 
diabetes-related information. Participants received instruction on accessing Diabetes MAP, used 
the site independently for two weeks (n=29), then provided feedback via a survey (n=29) and/or 
a focus group session (n=27). Survey data were analyzed descriptively. Focus group data were 
coded and analyzed thematically. 
Participants were, on average, 51.7±11.8 years old, female (66%), non-Hispanic White 
(60%), privately insured (78%), educated (31% with >12 years), and half had household incomes 
>$50,000. Average diabetes duration was 7.8±6.4 years; average A1C was 7.4 ± 2.0; and 38% 
used insulin. Most survey participants (75%) agreed Diabetes MAP was easy to learn and/or 
(89%) its information was clear and easy to understand. However, 28% reported navigational 
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challenges and/or (32%) difficulty recovering from errors. In focus groups, participants reported 
experiencing many errors, but liked the site’s design and easy access to medication information. 
Participants recommended improving the site’s user interface to facilitate quick, efficient 
completion of site-related tasks. 
Usability issues, such as difficulty navigating, understanding, and completing tasks are 
barriers to using and benefiting from Diabetes MAP. Appropriate usability testing ensures 
Internet-delivered interventions work as intended to improve health behaviors and outcomes. 
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INTRODUCTION 
 
Recent health reform efforts, such as the Health Information Technology for Economic 
and Clinical Health (HITECH) Act and the Patient Protection and Affordable Care Act 
(PPACA), support the rapid adoption and “meaningful use” of health information technology 
(HIT) (Blumenthal, 2010; Glabraith, 2013). Among the aims of these efforts is the facilitation of 
improvements in health management and quality of care. Consequently, recent research has 
explored the feasibility of HIT, including web-based applications, as feasible media for 
healthcare delivery.  
Web-based applications have been shown to be useful for health service delivery, 
particularly within patient-centered healthcare models and for behavior change interventions 
(Wantland, Portillo, Holzemer, Slaughter, & McGhee, 2004). While a substantially greater 
majority (~90%) of HIT implementations have yielded positive outcomes, some studies have 
highlighted negative outcomes, including poor patient satisfaction and user acceptance of HIT 
innovations (Buntin, Burke, Hoaglin, & Blumenthal, 2011). HIT validation techniques, such as 
user-centered design and usability testing, provided important insights regarding the efficacy of 
HIT innovations and their utility for health service delivery (Karsh, Weinger, Abbott, & Wears, 
2010). 
Web-based HIT applications have been particularly effective for improving diabetes 
health outcomes (McMahon, et al., 2005). Web-based interventions were efficacious delivery 
systems, especially for those managing chronic conditions that require self-management (Davis 
Kirsch & Lewis, 2004). Consumer- or patient-driven interventions for diabetes patients have 
yielded positive effects for intermediate health outcomes (Gibbons, et al., 2011). However, 
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essential to the success of consumer-based, web-based health interventions is user-centered 
design of interventions that are both usable and accessible to the targeted user population 
(Goldberg, et al., 2011). 
The purpose of this study is to examine the usability of the Diabetes Medication 
Adherence Program (Diabetes MAP) – a web-based health intervention designed to improve 
medication adherence behaviors in diabetes patients. This study is situated within a larger grant-
funded project to design, implement, and evaluate the effectiveness of a web-based application to 
improve medication adherence and diabetes health outcomes in patients with type 2 diabetes 
mellitus (T2DM). In examining the usability of Diabetes MAP, the following research questions 
are posed:  
1. To what extent do diabetes patients find Diabetes MAP to be a user-friendly tool?  
2. What are some of the usability challenges associated with Diabetes MAP?  
3. What are some ways that the usability of Diabetes MAP can be improved? 
In the following chapter, relevant literature pertaining to diabetes, medication adherence, 
and interventions that aim to promote medication adherence and improve diabetes health 
outcomes is reviewed. Then, methods for designing and testing the usability of technology-based 
health interventions are described. Finally, the web application, usability evaluation method, and 
findings from mixed methods analysis of patient reports of their experiences using Diabetes 
MAP are all described. 
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CHAPTER 1 
 
LITERATURE REVIEW 
 
Non-adherence to medications is a major public health problem, especially for patients 
with diabetes. Studies suggested patients with chronic diseases take only about fifty percent of 
the prescribed doses of their medications (Kocurek, 2009). For people with diabetes, suboptimal 
adherence to medications was associated with suboptimal glycemic control, increased risk of 
hospitalization and mortality, higher health costs and increased risk of long-term diabetes 
complications (Asche, LaFleur, & Conner, 2011; Balkrishnan, et al., 2003; Ho, et al., 2006; 
Sokol, McGuigan, Verbrugge, & Epstein, 2005; Krapek, et al., 2004; Rhee, et al., 2005; van 
Dulmen, et al., 2007).  Studies in diabetes and other chronic disease contexts (i.e., human 
immunodeficiency virus [HIV]) suggested a patient’s medication adherence depends on his/her 
disease-related knowledge, motivation, and skills (Amico, Toro-Alfonso, & Fisher, 2005; Fisher, 
Fisher, Amico, & Harman, 2006; Osborn & Egede, Validation of an Information–Motivation–
Behavioral Skills model of diabetes self-care (IMB-DSC), 2010). Interventions that leveraged 
the use of web-based applications to address these factors were found to effectively improve 
adherence (Fisher, et al., 2011). In the following section, we review relevant literature pertaining 
to diabetes medication adherence, web-based interventions designed to improve diabetes self-
care, and the methods used to evaluate web-based interventions, with a special focus on usability 
testing.  
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Diabetes Medication Adherence 
Non-adherence to medications is a prevalent and serious public health concern. The 
World Health Organization (WHO) projected that 157 million Americans will be affected by at 
least one chronic condition that requires medication therapy (U. S. Centers for Disease Control 
and Prevention, 2013). It was estimated that from 33-69% of medication-related hospital 
admissions are attributed to poor medication adherence, resulting in about $100 billion in U.S. 
healthcare costs annually (Osterberg & Blaschke, 2005). Adherence to a medication regimen 
refers to the “extent to which patients take medications as prescribed by their healthcare 
providers” (p. 487). This definition implicates both patients and providers to a clinical agreement 
established between the two describing the patients’ prescribed therapy.  
Non-adherence to medications is especially prevalent and costly for people with diabetes, 
who manage both complex and multidimensional treatment regimens. The lack of adequate 
treatment adherence was prevalent in the diabetes population at rates ranging from 36-87% (Lee, 
Balu, Cobden, Joshi, & Pashos, 2006). The CDC (2013) estimated that improved chronic illness 
self-management and adherence would result in a 1:10 cost-to-savings ratio. Non-adherence to 
medication regimens is associated with many dire outcomes for patients managing chronic 
illness. Chronically-ill patients with higher adherence to their medications experience lower rates 
of hospitalization (Sokol, McGuigan, Verbrugge, & Epstein, 2005), fewer inpatient hospital days 
and emergency hospital visits, and more regular visits with their healthcare providers than non-
adherent patients (Roebuck, Liberman, Gemmill-Toyama, & Brennan, 2011). When adherent 
patients faced higher pharmacy costs, their annual overall healthcare spending was also 
significantly lower than for non-adherent patients. 
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Patients with diabetes face unique outcomes and severe health consequences as a result of 
non-adherence to their medications. Only one in three patients with T2DM were found to have 
adequate (i.e., ≥90%) medication adherence to oral medications (Donnan, MacDonald, & Morris, 
2002). Insulin adherence among T2DM patients was as low as 62% in some studies (Cramer, 
2004). Consistently across multiple studies, suboptimal diabetes medication adherence was 
strongly associated with poorer glycemic control, higher blood pressure, LDL cholesterol levels, 
and higher rates of mortality (Balkrishnan, et al., 2003; Roebuck, Liberman, Gemmill-Toyama, 
& Brennan, 2011). Additionally, non-adherent patients encountered higher rates of healthcare 
utilization and hospitalization and increased medical costs (Asche, LaFleur, & Conner, 2011; Ho, 
et al., 2006; Lee, Balu, Cobden, Joshi, & Pashos, 2006; Sokol, McGuigan, Verbrugge, & 
Epstein, 2005; van Dulmen, et al., 2007).  
Researchers have long studied the factors that posing barriers to medication adherence for 
patients managing chronic illness. Several studies cited regimen complexity, psychosocial factors 
(i.e., depression), health literacy and medication costs as patient barriers to taking diabetes 
medications (Odegard & Capoccia, 2007; Odegard & Gray, 2008). Other researchers noted the 
rising cost of medications as a barrier to medication adherence (Hepke, Martus, & Share, 2004).  
However, while adherent patients did encounter increased medication-related costs, this increase 
was more than offset by overall reductions in medical costs due to decreased healthcare 
utilization and hospital costs (Roebuck, Liberman, Gemmill-Toyama, & Brennan, 2011; Sokol, 
McGuigan, Verbrugge, & Epstein, 2005). 
Evidence linking increases in diabetes medication adherence to subsequent improvements 
in other chronic illness outcomes, such as morbidity, mortality, quality of life, patient 
satisfaction, healthcare utilization, and costs, is limited and inconsistent (U. S. Centers for 
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Disease Control and Prevention, 2013). In a review of literature on the associations among 
diabetes treatment adherence, clinical and economic outcomes, scholars found consistently 
across studies that better adherence to treatment regimens was associated with improved 
glycemic control and decreased healthcare resource utilization (Asche, LaFleur, & Conner, 
2011). Although studies showed that patients who are adherent to their medication have more 
positive health statuses, no causal relationship between the two has been found. Interventions 
that improve medication adherence in patients induced only modest effects on health outcomes 
of those patients (McDonald, Garg, & Haynes, 2002). The complex relationship between 
medication adherence and health outcomes necessitate the meticulous design of research on 
interventions promoting medication adherence behaviors, such that observed intervention effects 
can actually be attributed to the intervention itself. 
 
Medication Adherence Interventions 
Current methods for improving adherence to medications for chronic disease 
management are mostly complex and are not very effective, as full benefits of treatment are often 
not realized. Even the most effective methods have very few practical improvements in 
medication use and health (Haynes, Ackloo, Sahota, McDonald, & Yao, 2008). Current 
approaches to improving medication adherence for patients with chronic disease are typically 
complex, labor-intensive, and are modestly, but not predictably effective (McDonald, Garg, & 
Haynes, 2002). While no clear advantage of a particular method or approach was evident, 
comprehensive interventions that combine cognitive, behavioral, affective, informational, or 
social components were more effective than single-focus interventions (Kripalani, Yao, & 
Haynes, 2007; Roter, et al., 1998). 
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Research on medication adherence has aimed to deconstruct the complexity regarding 
factors related to adherence behaviors and associated health outcomes. A study aimed at 
deconstructing these factors highlighted how patients’ diabetes medication-related knowledge, 
motivation, and self-efficacy skills were the modifiable factors related to medication adherence 
(Osborn & Egede, 2010). These factors mapped onto the Information-Motivation-Behavioral 
skills (IMB) model, which assumes that an individual’s health-related information, motivations, 
and behavioral skills are determinants of health outcomes (Fisher & Fisher, 2002). Applied in the 
context of HIV prevention, the authors stated, “the extent to that individuals are well informed, 
motivated to act, and possess the behavioral skills required to act effectively, they likely to 
initiate and maintain patterns of HIV prevention behavior” (p. 45). This model informed 
adherence promotion interventions in diabetes (Fisher, Kohut, Schachner, & Stenger, 2011; 
Osborn & Egede, Validation of an Information–Motivation–Behavioral Skills model of diabetes 
self-care (IMB-DSC), 2010) and other disease contexts (i.e., HIV) (Fisher, Fisher, Amico, & 
Harman, 2006; Horvath, Smolenski, & Amico, 2013). 
In light of the complexity of factors relating medication adherence to health outcomes 
and the complex structure of traditionally-delivered (i.e., face-to-face) interventions effectively 
promoting medication adherence behaviors, Internet-based interventions may be a feasible 
approach to delivery. Internet-based intervention that that leveraged technology as a delivery 
modality constituted viable approaches to improving diabetes medication adherence (Fisher, et 
al., 2011). This current study assumes this approach to intervention delivery, focusing on the 
Diabetes MAP, a web-based intervention designed for patients with T2DM that draws on the 
IMB model for promoting medication adherence behaviors. In the following section, we review 
the merits and challenges of designing web-based health interventions. 
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Internet-based Health Intervention 
Internet and computer use has soared over the past 25 years. Currently, 87% of American 
adults use the internet, with near-saturation usage among those living in households earning 
$75,000 or more (99%), young adults ages 18-29 (97%), and those with college degrees (97%) 
(Pew Research Center, 2014). As Internet usage rises in the United States, more people than ever 
are “online health seekers,” who access health information through online sources (Pew 
Research Center, 2013). With more Americans accessing web-based sources each year, and as a 
growing proportion of Internet users access the web for health information, web-based health 
intervention is increasingly becoming a feasible approach to health service delivery. 
Interventions designed to promote positive health behavior change have been delivered 
effectively through Internet-based technologies. One review compared the effectiveness of web-
based and non-web-based health interventions, and found improvements in knowledge and 
behavioral outcomes for patients using web-based interventions (Wantland, Portillo, Holzemer, 
Slaughter, & McGhee, 2004). Scholars noted that the use of new information technologies, as 
opposed to other implementation delivery modalities (i.e., one-on-one counseling interventions, 
group sessions, tele-health, mail interventions, and policy interventions), may extend and 
improve the reach, adoption, implementation, and maintenance of interventions for an overall 
increased public health impact (Glasglow, McKay, Piette, & Reynolds, 2001). Interactive 
behavior change technologies (IBCT), such as patient websites, utilize software and hardware to 
promote and sustain behavior changes in patients.  
IBCTs are one medium to provide diabetes patients with access to resources, web tools 
and health knowledge when, where, and through modalities that, otherwise, may not be available 
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(Piette, 2007; van Vugt, deWit, Cleijne, & Snoek, 2013). Studies showed Internet-based 
interventions to be effective, particularly for improving diabetes self-care behaviors (Barrera, Jr., 
Glasglow, McKay, Boles, & Feil, 2002; McMahon, et al., 2005). One benefit of e-Health and 
other technology-based interventions was cost-effectiveness relative to other types of delivery. 
One study examined the costs of developing Internet-based interventions for people living with 
HIV and revealed that, although developing an Internet-based medication adherence intervention 
was initially expensive, the monthly cost of implementing and delivering the intervention was 
low (Page, Horvath, Danilenko, & Williams, 2012).  
There is great enthusiasm and promise regarding the use of patient websites for health 
intervention. Internet-delivered interventions are amenable to widespread dissemination, 
adoption, and maintenance for public health purposes (Bennett & Glasglow, 2009). Another 
benefit of web-based interventions is the potential for interactivity for users (Murray, 2012), and 
the potential to address the needs of diverse patient populations through incorporating 
individually tailored elements (Ramadas, Quek, Chan, & Oldenburg, 2011). Interventions for 
patients managing chronic illnesses through self-care practices should aim to meet user 
expectations regarding the tool’s utility, and should be attentive to user-centered design 
standards. 
However, myriad studies reveal challenges to using HIT for the management of chronic 
illness (Glasglow, et al., 2011; Lyles, et al., 2011). In particular, poorly designed patient websites 
discouraged usage by patients (Nijland, van Gemert-Pijnen, Boer, Steehouder, & Seydel, 2008; 
Yu, et al., 2012). The effects of the usability and accessibility of technology-delivered 
interventions and their features on patient outcomes have been researched in other contexts. One 
such study explored the feasibility of a web- and mobile technology-mediated intervention for 
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adolescents (Mulvaney, Anders, Smith, Pittel, & Johnson, 2012). In this pilot study, preliminary 
findings yielded no change in glycemic control (measured by A1C) for the intervention group, 
accompanied by an increase in glycemic control for the control group. The study underscored the 
importance of examining usability of technology-based interventions, while also highlighting the 
feasibility of the delivery modality. 
A review of recent studies revealed benefits of patient web-based portals for patient 
outcomes, patient-provider communication, disease management, and access to and patient 
satisfaction with healthcare. While intervention effects were moderate but inconsistent, there was 
a high prevalence of issues related to the usability of interventions across studies (Osborn, 
Mayberry, Mulvaney, & Hess, 2010). 
 
User Experience, Usability, and Usability Evaluation 
User experience and user-centered design are core elements for designing and developing 
web applications. User experience “focuses on having a deep understanding of users, what they 
need, what they value, their abilities, and also their limitations” (U.S. Department of Health and 
Human Services, 2014). User experience is an application of information architecture that 
considers the context of users, user needs and behaviors, and the integration of a mix of content 
(Morville, 2004). Figure 1 depicts the qualities of user experience. A website should be useful, 
desirable, accessible, credible, findable, and usable. 
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Figure 1. Facets of Web User Experience (U.S. Department of Health and Human Services, 
2014). 
 
This sixth factor listed above – usability – is a core tenet for constructing the web user 
experience and applying web user-centered design, and thus is the focus of the current study. A 
website’s usability refers to the extent to which users can effectively, efficiently, and 
satisfactorily interact with a web user interface (U.S. Department of Health and Human Services, 
2014). Web usability involves a combination of factors, including: 1) intuitive web design; 2) 
ease of learning a user interface; 3) efficiency of website use and task completion; 4) 
memorability; 5) error frequency, severity, and recovery; and 6) user subjective satisfaction. 
Usability concerns four major components of project design – user, tool, task, and environment 
(Yen & Bakken, 2012).  
Usability is a key factor enabling user acceptance and adoption of Internet-based 
applications for disease management. Web-based health interventions that are not usable and 
USEFUL- content must be original and fulfill a need
DESIRABLE- design elements are used to evoke emotion and appreciation
ACCESSIBLE- needs to be accessible to all user groups (i.e. people with disabilities)
CREDIBLE - users must trust and believe content
FINDABLE - content needs to be navigable and locatable
USABLE - site must be easy to use
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accessible to users can prevent patients from reaping the health benefits of using the website. 
This study endeavors to evaluate the usability of a web-based health intervention that features 
interactive and individually tailored components for diabetes patients. Usability testing and 
evaluation is conducted in order to determine if websites and their embedded tools are usable for 
web task completion for their targeted user bases. 
Web usability testing entails evaluating a website by testing it with a group of 
representative users. Usability testing involves “a process of involving users to evaluate a system 
to ensure that is meets usability criteria” (Corry, Frick, & Hansen, 1997, p. 67). With a primary 
goal to improve the usability of a product, usability testing involves real users who participate in 
real tasks. Their interactions with the system and feedback regarding their experience is 
observed and recorded. Then finally, data are analyzed, and recommended changes are made 
(Dumas & Redish, 1999). For user testing, web usability is primarily assessed along three 
dimensions: 1) effectiveness, or the match between goal of users and the extent to which users 
can achieve them within a system; 2) efficiency, or the level of effectiveness that is achievable 
for an expenditure of resources in a system; and 3) satisfaction, or user attitudes toward using a 
product or system (Yen & Bakken, 2012). 
There are many methods for evaluating the usability of a system, including: user testing 
of an existing site, focus groups, surveys, contextual or individual interviews, card sorting, wire-
framing, click testing, personas, scenarios, task analysis, heuristic evaluation, expert review, 
remote user testing and satisfaction surveys (U.S. Department of Health and Human Services, 
2014). Usability evaluation can occur at one or more of several junctures across the web system 
development life cycle, with usability testing typically occurring in the final stages of 
development. Common approaches to usability testing in the final stages of website design 
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include observation, interviews, and focus groups (Yen & Bakken, 2012). Usability evaluation 
methods vary by cost, timeframe, the number of users/evaluators needed, the types of data 
collected, and the level of structure required to complete the evaluation. The planning process for 
usability testing requires setting goals for the usability test, defining sample users, selecting tasks 
and scenarios, and determining how usability will be measured (Matera, Rizzo, & Carughi, 
2006). 
 Web usability evaluation methods can employ expert-driven and/or user-driven 
approaches (Jaspers, 2009). Expert-based methods uncover potential usability problems by 
having evaluators inspect a user interface with an objective set of guidelines, heuristics, or 
questions in mind. User-based participatory methods introduce real end users to a user interface. 
These methods require them to talk through completing tasks and to explain what they are doing. 
User-based usability evaluation methods elicit feedback from representative users regarding their 
perceptions of a website’s usability. User-based inspection methods usually require at least five 
representative users in order to elicit about 80% of the major usability issues existing within a 
system qualitatively (Nielson, 2000). For quantitative analysis, at least 20 representative users 
are needed for statistical analysis. Qualitative user testing methods are better suited for 
determining why or how to fix a problem, while quantitative methods help you to understand the 
number and type of issues encountered with a system (Rohrer, 2008). 
User-based usability evaluation is used to provide evidence of the usability of a system 
based on the feedback from the target audience. Target users are given realistic tasks in realistic 
situations, and are given minimal assistance to do so (Petrie & Bevan, 2009). Formative user-
based methods focus on users’ behaviors, intentions, and expectations in order to understand the 
problems encountered and are conducted prior to the design of a system. Summative user-based 
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methods measure the product usability, and are used to test and establish user requirements at the 
end of the system design cycle. User-based evaluation methods require from 8-30 participants. 
There is little research to date that examines the feasibility of using interactive web 
technology to support medication adherence and the salience of the features of these 
interventions for this population. The current study utilized a combination of summative user-
based evaluation methods – focus groups and online usability questionnaires – to assess user 
perceptions of the usability of Diabetes MAP. Focus groups are a cost-effective and efficient 
method of evaluating usability that yield relatively valid data regarding a website’s design 
(Vredenburg, Mao, Smith, & Carey, 2002). Focus group evaluation is an informal web user 
testing technique that elicits user thoughts and preferences regarding their experiences using a 
website. Online structured questionnaires enables web designers to learn if a website meets the 
needs and expectations of users, and to identify areas needing improvement. 
 
Diabetes MAP 
Diabetes MAP is a self-guided, individually tailored, web-based therapeutic intervention. 
Self-guided web-based interventions are interactive and are often highly dynamic in nature. They 
can be delivered in modularized behavior change and highly structured delivery formats (Barak, 
Klein, & Proudfoot, 2009). Diabetes MAP was designed to promote medication adherence in 
patients with T2DM in accordance the IMB model for diabetes medication adherence (Osborn & 
Egede, 2010). Content delivered through the Diabetes MAP website focused on improving 
diabetes- and medication-related knowledge, personal and social motivation to take medications, 
and medication adherence behavioral skills. The intervention was tailored to individual users’ 
needs through a series of mechanisms that determine the most relevant content to display.  
  
15 
Table 1. 
Diabetes MAP Web Features 
Feature Feature Description 
“About” button After adding medications on the “My Medications” page, users may 
click the “About” button to learn side effects, medication-specific 
information. 
“Edit” button Users may edit medication information on the “My Medications” 
page by clicking the “Edit” button for each medication. 
Text message 
medication reminders 
Users may click a button on the “My Medications” page to open a 
window for text message reminders. Users specify their cell phone 
carrier, and then designate the times to receive text message dosage 
reminders each day, as desired for each medication. 
Text message refill 
reminders 
Users may click a button on the “My Medications” page to open a 
window for text message reminders. Users specify their cell phone 
carrier, and then designate the time intervals (i.e. every 30, 60, 90 
days) to receive text message refill reminders, as desired for each 
medication. 
Email medication list Users may click a button on the “My Medications” page to have a 
list of medications, frequencies, and dosages emailed to the email 
address used for login. 
Print medication list Users may click a button on the “My Medications” page to open a 
window to print a list of their medication names, frequencies, and 
dosages. 
Access patient portal Users may click a button on the “My Medications” page to open a 
window to the login page for the online patient portal. 
Access information, 
motivation, and 
behavioral skills-
related content 
Users may navigate to the “My Tailored Tools” page and click on 
one of three domains (i.e., Information, Motivation, or Skills) to 
access up to IMB-based 40 video and static text content modules. 
Recover user 
password information 
Users may click the “Forgot Password” link, then enter their 
registered email address to have their password sent to their email 
account. 
Edit account 
information 
Users may navigate to the “My Account” page in order to update 
their user account information. 
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On the Diabetes MAP home page, users created a user account. After logging in, users 
were directed to the “My Medications” page (see Appendix A for images of webpages), to enter 
their diabetes and non-diabetes medications, dosages, and frequencies. On this page, users could 
learn about each of their medications, email or print a medication list, set up text message 
medication and refill reminders, or click a link to access the online patient web portal. 
After learning about their specific medications, users were automatically directed to a 
medication checklist questionnaire. Here, users answered thirty questions regarding their 
medication adherence, knowledge, motivations, and skills. After completing the questionnaire, 
users were directed to the “My Tailored Tools” page that houses the remainder of the 
intervention content. Videos, static text and images were organized into three categories of 
modules located in three different sub-windows on the “My Tailored Tools” page. Table 1 
describes the list of features embedded into the Diabetes MAP website. 
Table 2. 
Diabetes MAP Online User Tasks 
Task Task Description 
Create an account From the Diabetes MAP landing page, users click “First-Time User”. 
Then, users enter an email address, a user-defined password, their 
mobile phone number, time zone, gender, date of birth, and security 
questions and answers. Users click “OK” to save information. 
Login to user 
interface 
Users enter their registered email address and password, then click 
“Enter”. 
Add medications On the “My Medications” page, users click the “Add Medication” 
button. Users may search medication names, then select the dosage 
and frequency of doses for each one of their diabetes and non-
diabetes medications. 
Complete medication 
checklist 
questionnaire 
After adding medications, users are directed to a Medication 
Checklist questionnaire. Users answer 29 questions to rate 
themselves on medication related knowledge, personal and social 
motivation, and medication-taking skills. 
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Based on user responses, modules proliferated under three domains – Information, 
Motivation, and Skills – to provide information and support to users around the areas that they 
indicated needing improvement in the checklist questionnaire. For example, patients could view 
a video about metformin, an oral medication frequently prescribed to patients with T2DM, or one 
on how to be “incognito” while taking medications in public spaces. Users could revisit the site, 
add/modify/delete medications, and view intervention content by re-entering their login 
information on the home page. Table 2 lists the tasks that users must complete to optimize their 
experience using Diabetes MAP. 
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CHAPTER 2 
 
METHOD 
 
Site Selection & Field Entry 
The study took place in mid-sized city in the southeastern region of the United States. 
Adult diabetes patients were recruited from an academic medical center diabetes patient 
community using multiple recruitment mechanisms. This site was selected due to the availability 
of access for patients seen at the medical center to an online patient portal that is linked to the 
Diabetes MAP web application. Institutional review board approval to conduct the study was 
obtained from the academic medical center via expedited review. 
This project was a part of an ongoing research project based in this academic medical 
center. The principal investigator leveraged ongoing relationships with administration in the 
diabetes and primary care clinics to collaborate on recruiting diabetes patients to be participants 
in the study. Together, the principal investigator, study coordinator, and medical center 
administration (i.e., nurse liaison, clinic director) from each of the clinics met to plan for 
recruitment that would not interfere with, or delay the flow of operations in each clinic.  
 
Recruitment 
A convenience sample was recruited using flyers, referrals from healthcare providers, 
medical center list-servs, and in-person solicitations. Adult T2DM patients aged 18 and older 
were recruited from the adult primary care and diabetes clinics. Additionally, participants were 
recruited from a pool of participants from a previous study who had indicated on informed 
  
19 
consent forms that they were willing to be contacted for future diabetes-related studies. The 
individuals from this list were contacted through their preferred method indicated on the consent 
form. The research team took targeted steps (i.e., culturally inclusive flyers) to enroll adult 
T2DM patients that were diverse with respect to age, gender, race, ethnicity, and experience. 
Inclusion criteria.  
 Individuals who were adults aged 18 years and older (confirmed via electronic 
health record)  
 Individuals who have received a diagnosis for type 2 diabetes mellitus (confirmed 
via electronic health record)  
 Individuals who were enrolled as a patient in the academic center’s adult primary 
care or diabetes clinics  
 Individuals who were currently being treated with oral and/or injectable diabetes 
medications (confirmed via electronic health record)  
Exclusion criteria.  
 Individuals who were non-English speakers (determined subjectively by a trained 
research assistant due to lack of resources available for translation services)  
 Individuals who reported that they do not have a mobile phone or computer with 
Internet access  
 Individuals who were unwilling and/or not able to give written informed consent  
 Individuals who had unintelligible speech (e.g., dysarthria) (determined 
subjectively by a trained research assistant) 
 Individuals with delirium or a severe cognitive impairment (determined by a 
reported lack of orientation to person, place, and time)  
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 Individuals with a severe hearing or visual impairment (participant self-report)  
 Individuals with a caregiver who administers all medications (participant self-
report)  
 
Enrollment 
Eligible patients were identified by a clinic staff member and notified of the opportunity 
to participate in the research project. Participants were also recruited in waiting rooms via 
flyer/email solicitation and from a pool of individuals who had consented previously to be 
contacted for future diabetes-related studies. Interested patients contacted the study coordinator, 
who then described the study procedures, as well as the benefits and costs of participating. 
Participants attended an enrollment meeting, wherein informed consent was obtained by having 
participants read an IRB-approved consent form and then agree to the procedures. The schedule 
for participant compensation was also explained in the enrollment meeting. Participants were 
reimbursed at the close of the study for time spent and transportation to and from the study site 
for the enrollment meeting. Figure 2 depicts the flow of participants from recruitment to study 
completion. Of those who were eligible and consented to participate (N=32), 84% (n=27) 
completed all parts of the study. Three participants completed the enrollment survey (ES) only, 
and two participants completed the ES and follow-up web usability survey (WUS). 
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Figure 2. Participant Flowchart 
 
Data Collection & Handling 
Qualitative and quantitative data collection methods were utilized across four data 
collection points: (a) an enrollment meeting, (b) electronic chart review, (c) a follow-up survey, 
and (d) a focus group session. 
Enrollment meeting. During the enrollment meeting, eligible participants completed the 
ES to officially enroll in the study. A trained research assistant received an interview protocol to 
follow administered the ES interview. Participants also had the option of completing a paper 
version of the survey, or an electronic survey on a laptop during the enrollment meeting. 
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Enrollment meetings took place in a private space in the academic medical center and took 30-45 
minutes to complete. A trained research assistant entered survey data into a Research Data 
Capture (RedCAP) database (Harris, et al., 2009). Self-report data on participants’ of medication 
knowledge, medication adherence, health literacy, general computer usage, and health 
communication preferences were collected in the ES. 
Electronic chart review. After the enrollment meeting, diabetes diagnoses, hemoglobin 
A1c (HbA1c) history, medication history, and other diabetes-related health information were 
extracted for each participant via electronic health chart review.  
Web Usability Survey and Focus Group. After exploring the Diabetes MAP website in 
other settings (i.e., home, work, etc.), Study participants were asked to complete the web 
usability survey (WUS) individually prior to the start of the focus group interview (paper or 
electronic version). The WUS took 15-30 minutes to complete.  
Participants returned to the medical center for the in-person focus group interview, were 
asked to share their experiences using the Diabetes MAP website, and given the opportunity to 
provide feedback. Two to five participants attended each one of nine focus group sessions. A 
trained research assistant conducted the focus group interview. Interviewers received a semi-
structured focus group protocol to follow with a priori questions regarding users’ experiences 
with the website (see Appendix B for focus group protocol). The focus group interviewer 
demonstrated features and tasks that were ideally performed within Diabetes MAP, while 
eliciting responses from participants on their impressions of them. This is a method similar to the 
pluralistic walkthrough usability evaluation method “uses group meetings where users, 
developers, and human factors people step through a scenario, discussing each dialogue element” 
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(Nielsen, 1995, para. 1). Focus group interviews ranged from 60-90 minutes, and were audio-
recorded.  
Transcripts were created from the focus group audio recordings and were de-identified of 
participant demographic information. The recordings and transcripts from focus groups were 
saved electronically, password-protected and retained on a secure server in the medical center. 
Survey data was recorded and stored electronically. Original paper copies of the surveys were 
filed in a locked file cabinet in the medical center. Original audio-recordings of participants and 
written field notes will be retained in this location for up to ten years, and then will be destroyed.  
Participant identifiers were retained only for financial and regulatory research purposes. 
Participant identifiers were password-protected and stored separately from any associated data. 
Participants were given randomly assigned codes associated with their identifiable information. 
Only the participant identification code was included on any data files. Participants were 
compensated $25 for their time at the enrollment meeting, $8 per hour for each full hour spent 
exploring the website (up to ten hours; times was recorded using the web analytics software), 
$35 for participation in a focus group session, and $15 for completion of the WUS. Participants 
earned up to $155 for full study participation and received payment within six weeks of the close 
of the study. 
 
Measures 
Demographics and basic diabetes information. Self-report data on diabetes diagnosis 
(i.e., length of time with diabetes, type of diabetes), diabetes medication types (i.e., oral or IV 
injected medications, number of diabetes medications), and demographics were collected from 
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each participant via the ES. Demographic variables included race/ethnicity, gender, years of 
education, annual household income, occupation, and health insurance status. 
Glycemic control. Patients’ most recent hemoglobin A1c (HbA1c) was extracted 
through electronic chart review. HbA1c provides a snapshot of a person’s average glucose 
control for the previous 2-3 months prior to the test (American Diabetes Association, 2013). For 
the current analysis, the most recent HbA1c (A1C) is proxy for glycemic control. 
Website usability. Participant perceptions of Diabetes MAP’s usability were assessed 
using ten individual items adapted from the Computer System Usability Questionnaire (CSUQ) 
(Lewis, 1993). Items included questions like, “Overall, it was easy to learn to use Diabetes 
MAP” and “When I make a mistake in Diabetes MAP, I recover easily and quickly.” Responses 
ranged from 1 (strongly disagree) to 5 (strongly agree), with higher scores indicating 
endorsement of the website’s usability. 
 
Data Analysis 
Qualitative methodologies focus on “how people perceive their worlds and how they 
interpret their experiences” (Rubin & Rubin, 2012, p. 15). As described above, qualitative data 
were collected through focus group interviews and were transcribed. Selective coding for web 
usability themes was performed on the transcript data. Selective coding acknowledges a central 
phenomenon in a study, and “ is the process by which all categories are unified around a central 
‘core’ category” (Corbin & Strauss, 1990, p. 15). Codes were analyzed and interpreted using 
theoretical thematic analysis.  Theoretical thematic analysis is a “top-down”, deductive 
approach to qualitative analysis, whereby researchers may analyze and interpret data around a 
theoretical or analytic area of interest with great detail (Braun & Clarke, 2006). Coding and 
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analysis centered on the six sub-themes of usability: (a) intuitive web design, (b) ease of learning 
the user interface, (c) efficiency of use, (d) memorability, (e) errors and recovery, and (f) user 
subjective satisfaction. This coding schema facilitated the identification of concepts within 
categories among user reports of usability-related issues, challenges, and recommendations for 
Diabetes MAP. 
Survey data were also examined. Demographic data from the ES were analyzed 
descriptively to characterize the sample of users. Health chart review data were used in order to 
verify participants’ eligibility, A1C, and number of diabetes medications. WUS data were 
analyzed to quantify and synopsize user reports of the Diabetes MAP website usability.  
 
Qualitative Data Quality 
Focus group usability evaluations were conducted until near-saturation of concerns was 
reached. Counts of the numbers of total and new issues introduced in each focus group were 
analyzed to determine if a significant proportion of the total major usability issues (e.g., ≥80%) 
were found early in the study. To ensure the quality and trustworthiness of qualitative analyses, 
the investigator and study coordinator met for debriefing sessions after each focus group to 
discuss themes and to review RA-written field notes. Disagreements about the meanings of 
participant responses and comments were reconciled through discussion and consensus. We 
conducted comparative analysis via methods and analyst triangulation to compare data across 
data collection methods (i.e., electronic and paper surveys), data sources (i.e., survey and focus 
group data) and data reviewers (i.e., RA and PI) (Patton, 1999). Negative case analysis was 
highlighted wherever present in the data. Finally, rich descriptions are provided in this report that 
reflect concepts, categories, and themes prevalent in the data.  
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CHAPTER 3 
 
FINDINGS 
 
Participant Demographics 
We recruited a racially, ethnically, and health status-diverse, locally representative (i.e. 
academic medical center patients) patient sample, although not representative of the national 
diabetes population. On average, participants were 51.7 ± 11.8 years old, female, educated, non-
Hispanic White, and privately insured. Half of the participants had annual household incomes 
greater than $50,000.  
The sample also spanned a broad range of educational attainment, glycemic control, and 
diabetes duration. Users had diabetes diagnoses that ranged from 0 to 20 years. Almost 40% of 
the sample consisted of insulin users. The average A1c for participants was 7.4, which is well 
above the threshold for acceptable glycemic control (≥6.5%) (American Diabetes Association, 
2014). All participants had access to computers or cell phones, yet evinced multiple levels of 
comfort using the Internet and computer/digital technologies. This diversity ushered in a broad 
range of perspectives, areas of expertise, and sources of motivation for improving the usability of 
a diabetes web-based health intervention. Table 3 presents the characteristics of participants who 
completed the baseline assessment with means, standard deviations and percentages.  
 
Usability Survey Data 
Users offered moderate to favorable ratings for the usability of Diabetes MAP. On a scale 
of 1 to 5 with higher values representing more favorable ratings of usability, the average rating 
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across all individual items assessing usability was 3.86. Table 4 shows the number of 
respondents, the average rating, and the proportion of “endorsers” that either responded 4 – 
“agree” or 5 – “strongly agree” with the usability items.  
Table 3. 
Demographic characteristics of participants (N=32) 
 Mean ± SD or n (%) Range 
Age (years) 51.7 ± 11.8 26.7 – 73.4 
Female 21 (66)  
Race/Ethnicity   
Black (non-Hispanic) 8 (25)  
Hispanic 3 (9)  
Asian 2 (6)  
White (non-Hispanic) 19 (60)  
Education (years) 16.3 ± 2.8 12.0 – 24.0 
Annual Household Income   
Less than $14,999 3 (9)  
$15,000 to $24,999 3 (13)  
$25,000 to $49,999 9 (28)  
$50,000 and $74,999  7 (22)  
$75,000 or more  9 (28)  
Number of Diabetes Medications 1.8 ± 0.8 1.0 – 4.0 
Insurance Status   
Private insurance 25 (78)  
TennCare/Medicare 6 (19)  
No insurance 1 (3)  
Diabetes duration (years) 7.8 ± 6.3 0.0 – 20.0 
Insulin users 12 (38)  
A1C (n=31) 7.4 ± 2.0 4.9 – 15.8 
1 One participant had no A1c included in medical records at the time of data collection.  
 
The highest ratings (4.2) and highest proportion of “endorsers” (80%) resulted from 
the following items: 1) “the information provided in Diabetes MAP is easy to understand,” and 
2) “the information (such as help videos, on-screen messages, etc.) provided in Diabetes MAP is 
  
28 
clear”. The lowest ratings (3.6) and lowest proportion of “endorsers” (62%) resulted from the 
following items: 1) “it is easy to navigate the Diabetes MAP website,” 2) “the information 
provided in Diabetes MAP is effective in helping me complete tasks on the website”, and 3) 
“when I make a mistake in Diabetes MAP, I recover easily and quickly.” 
 
 
Table 4. 
User Perceptions of Diabetes MAP Usability 
 
Respondents1, 2 
n 
Endorsers3 
n (%) Mean  ±  SD 
It is easy to navigate the Diabetes MAP 
website. 
29 18 (62) 3.6 ± 0.9 
My user interaction(s) with Diabetes MAP 
are pleasant. 
27 20 (74) 4.0 ± 0.9 
The organization of information in Diabetes 
MAP is clear. 
27 17 (63) 3.8 ± 0.9 
The information provided in Diabetes MAP 
is effective in helping me complete tasks on 
the website. 
27 15 (56) 3.6 ± 0.9 
The information provided in Diabetes MAP 
is easy to understand. 
28 25 (89) 4.3 ± 0.7 
It is easy to find the tools and information 
that I need. 
27 18 (67) 3.8 ± 0.9 
The information (such as help videos, on-
screen messages, etc.) provided in Diabetes 
MAP is clear. 
27 23 (85) 4.2 ± 0.8 
When I make a mistake in Diabetes MAP, I 
recover easily and quickly. 
26 15 (58) 3.5 ± 0.9 
Overall, I feel comfortable using Diabetes 
MAP. 
28 19 (68) 3.9 ± 1.0 
Overall, it was easy to learn to use Diabetes 
MAP. 
28 21 (75) 3.9 ± 1.0 
1Number of participants who provided a response for each item on a scale of 1 (strongly disagree) to 5 (strongly 
agree) 
2Some participants indicated that items were “Not Applicable” to their experience 
3Percentage of respondents who entered 4 (agree) or 5 (strongly agree) for an item 
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Focus Group Findings 
Participants shared their experiences exploring the features and performing tasks using 
Diabetes MAP. Users identified challenges and issues using the website, and offered 
recommendations for how it can be improved. Participants cited a total twenty-four unique 
usability concerns over nine focus group sessions. The concerns were sorted into six dimensions 
of usability: (1) intuitive web design, (2) ease of learning, (3) efficiency of use, (4) memorability, 
(5) user subjective satisfaction, and (6) error frequency and severity. A substantial majority 
(83%) of these unique issues were reported after only two focus group sessions. See Appendix C 
for a full list of issues and their reported incidence across focus group sessions. 
Concerns about error frequency and recovery constituted the most prevalent issue area 
across focus groups. The two most prevalent specific issues of all were reported in each of over 
half of the focus group sessions and pertained to the error frequency and severity dimension of 
usability. Participants frequently reported having encountered web browser compatibility-related 
problems and difficulty logging to the website. Also prevalent were concerns regarding the 
website’s efficiency of use and the intuitive web design. See Appendix D for the prevalence of 
reports of usability concerns across focus groups by usability dimension. In the following 
sections and  in Tables 5 – 10, each of the six dimensions of usability issues noted by 
participants and the recommendations that users provided to improve the website is discussed. 
Intuitive web design concerns and participant recommendations. Participants 
reported overlooking and missing out on the benefits of many features and functions due to 
inadequate web design. Intuitive web design denotes a “nearly effortless understanding of the 
architecture and navigation of a website” (U.S. Department of Health and Human Services, 
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2014, para. 4). By the end third focus group session, all six usability concerns regarding intuitive 
design of the website were reported at least once by a participant.  
 
One prevalent concern that emerged in this domain pertained to the navigability of the 
website within and between webpages. Participants were generally unaware of the individual 
tailoring mechanism behind the medication checklist questionnaire, and of the reasons for having 
to provide information, such as the time zone and mobile phone number (important for text 
Table 5. 
Participant Concerns and Recommendations Regarding Intuitive Web Design  
Issues Examples of Participant Response(s) 
Placement/layout of 
functionality/content not 
intuitive 
You [are] asked ten questions. “Okay, do you know why you are taking 
this medicine?” Yes. “Do you know the side effects from this?” No. 
When I say no, I expect an answer immediately. So it’s in the right now.  
Navigation - scrolling 
required to access site 
features/tasks 
When I filled out the survey, I realized how much I missed, like texting. 
Where was that? I am really frustrated because I would love that. The 
fact that I missed all that other stuff tells me that it was not accessible 
… I got frustrated when I was entering that medication and thought, 
heck! 
Issues navigating using 
buttons/navigation menu 
What we were saying earlier about having to, reload a whole page to 
go to something … Maybe have a Back button. 
Tailoring mechanism 
unclear to users 
The only [medication] taken from my list that came up in My Tailored 
Tools was metformin. My glimepiride was not there at all, even though 
it was under the “My Medications” thing. 
Navigation - need to be 
able to navigate away 
from Help videos 
Even if she just loaded, and you could skip her, like, skip intro. Like 
maybe you don't want her to talk you through ... You can just skip her, 
and then it will just give you a regular website, with nobody talking to 
you. 
Unclear that background 
was actually Help videos 
Well, no at first I saw her and I was going, "What is she doing?" And 
then finally I figured out you clicked that thing and she talked. 
Recommendations Examples of Participant Response(s) 
Minimize or eliminate the 
distracting “Pam” Help 
videos 
She is a very lovely woman. She takes up two-thirds of the screen every 
single time! I was scrolling all the way down. It may sound silly, but, 
you know, I am busy … Finally, at the very bottom, there is this much 
[gestures with fingers] content. 
Need more intuitive 
placement of features 
Make the system clearer. I guess, organize. We were talking about if 
[medication content] were better in the tailored section or the 
medications section. Make it more organized to where things are where 
they are supposed to be. 
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message reminder set-up). Users frequently encountered design issues, as a result of having to 
scroll from help videos to see webpage content and features. 
Although some users though the “Pam” Help videos were pleasant, some users were not 
able to get the Help videos to function properly, and others never new that there were even 
videos to play for Help information. Many participants suggested that the Help videos be 
minimized or eliminated to improve the design and navigability of the website. Other 
respondents noted some misplaced content and features across webpages, and made 
recommendations regarding intuitive layout. Table 5 summarizes the primary concerns expressed 
by participants and their recommendations regarding the intuitive web design of Diabetes MAP. 
Ease of learning and participant recommendations. Users encountered issues with the 
instructions and directions that were given for accessing the site and its features. A website’s 
ease of learning refers to “how fast a user who has never seen the user interface before can 
accomplish basic tasks” (U.S. Department of Health and Human Services, 2014, para. 4). All 
user interface-learning concerns were cited by the third focus group session.  
Users noted the a priori instructions handout lacked the detail necessary to spell out to 
users what tasks should have been performed. Further, users pointed out how the directions 
embedded within the website were unclear and, at times, misguiding and misdirecting. Users 
wanted Help videos to be functional, accessible, useful, and recallable when needed. Users also 
wanted clear, detailed instructions on how to optimize their experiences using the site. Table 6 
summarizes the major interface learning issues and recommendations that were reported by 
participants. 
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Efficiency of use and participant recommendations. Users encountered time 
inefficiencies as several junctures while using the website. Efficiency of use refers to “how fast 
an experienced user can accomplish tasks” (U.S. Department of Health and Human Services, 
2014, p. para. 4). Concerns regarding efficiency of use constituted the second most prevalent of 
usability sub-category (n=13) noted across focus groups. In particular, users reported extended 
durations of page loading and speculated that it was due to the large “Pam” Help videos. This 
issue was exacerbated as users attempted to access Diabetes MAP via other digital devices. 
Users expressed frustration with not being able to save progress toward completing website 
tasks, even when automatically logged out. Finally, users wanted easy methods of completing 
Table 6. 
Participant Concerns and Recommendations Regarding of Ease of Learning 
Issues Examples of Participant Response(s) 
Instructions accessing/using the 
website unclear 
In my department, when we have something new, especially with 
the computer software, whatever, a new program or something for 
employees to change, it goes step by step what to do … This one, 
maybe, it will help with the research, with the new people, here's a 
sheet of paper. If you go step by step, you can give it to anybody, 
even in the street, and they can do it. 
Directions within website 
unclear 
You’re supposed to add everything you can? See, I didn’t 
understand it that way. Nothing. Nothing told me, and I couldn’t 
get the girl to talk either. 
Help videos not useful for 
completing tasks/accessing 
features 
Not after the first time I went on there. I mean, I listened to her the 
first time I went on there, but then, I think I could have done it 
without her. 
Help videos dysfunctional Pam's bobbing and weaving, and Pam is slowing down the loading 
of the page. And I actually, sometimes, saw her image, even 
though when she was talking, blacked out. 
Recommendations Examples of Participant Response(s) 
Users want more detailed 
instructions and directions on 
using the website. 
If people get instructions beforehand, you know, they can say, 
"Okay, well off to here, you know, here's these and they mean 
that." You know, it should be obvious. 
Users want Help videos to be 
easy to access. 
I didn't find it very useful of her just being on there. Because I 
couldn't figure out how to get her to say anything. I spent a lot of 
time initially trying to get her to talk. It never could do it. 
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simple tasks, such as entering time zone information (i.e., a simple drop-down box rather than 
the time zone map). Users wanted to be able to track and save progress toward tasks and the 
capability to access the site from multiple digital platforms. Table 7 summarizes user reports of 
efficiency of use issues and participant recommendations. 
 
Memorability. Website memorability refers to the extent to which a user, after visiting a 
site, can remember enough to use it effectively in the future (U.S. Department of Health and 
Human Services, 2014). The memorability of Diabetes MAP, its features and tasks was primarily 
Table 7. 
Participant Concerns and Recommendations Regarding Efficiency of Use 
Issues Examples of Participant Response(s) 
Progress not saved If you do half of it, and you try to do something else, and the 
computer freezes or logs you out, you have to start all over again.  
Page loading time too long But the moving around kind of bothered me a little bit. It's closed 
the site down. A waste, I think. 
Time zone locator difficult to 
use 
First of all it wanted you to select what time zone you’re in. It 
would just remain blank and wouldn’t let me select a time zone, 
but then the next day it did. 
Automatic logout problematic But if you even scrolled or clicked up around that corner… It 
would log you out when you weren’t even on intending to.  Like I 
clicked on that diabetes map like thing… And it logged me out. 
Compatibility with other digital 
devices 
I felt it’s like it’s a little heavy to start with.  Um, my laptop still 
cannot open it. iPads can open it, but needs a lot of time, even I 
have high speed. When you open it in iPad, some clips, reader 
clips, you cannot get unless you are in desktop or laptop. 
Difficulty scrolling using child 
windows 
Sometimes when I was looking at the videos, I would try to make a 
selection. The bar on the right hand side would not go all the way 
down to the bottom. If it did, then it would hit the bottom and come 
back up. I couldn't make it stop. 
Recommendations Examples of Participant Response(s) 
Users want to be able to save 
their progress 
If there is a possible way, which is, I'm sure it is, to save it and 
come back to it to finish it? 
Users want more flexibility to 
use other electronic devices. 
I think first thing I would address is to make this friendly to all 
electronics. Cell phone is number one and then a home computer 
is important. 
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complicated by its confusing web address (URL). When users forgot or mistyped the web 
address, they resorted to using search engines or searched for links on the partnering medical 
center’s webpage to try to find the site. Users reported barriers to accessing the website due to 
the complex URL in three of nine focus groups.  
Users also frequently reported forgetting the actual purpose of the website. They noted 
that they were reminded of its purpose only after exploring the website and seeing primarily 
medication-related information. Users wanted a simple, recognizable, and memorable web URL 
for the site, and want to be able to find it through an online search in an efficient manner. Table 8 
summarizes the few memorability concerns and recommendations that were reported in this 
study. It is important to note, in almost half (n=4) of the focus group sessions, users conveyed 
that they had, at some point not been clear on the purpose of the website after being introduced 
to it with accompanying website information (i.e., handout). 
 
Table 8. 
Participant Concerns and Recommendations Regarding Memorability  
Issues Examples of Participant Response(s) 
Confusion regarding purpose of 
site/features 
I didn't even realize it was just for taking medications until we 
came to this focus group … But, I sort of realized it was all about 
medications, because I didn't see all of the other things I was kind 
of looking for. 
Complicated URL - not 
locatable 
Do you plan to use a user-friendlier name? My hope is Vanderbilt 
was specifically picked to be something you could find. We weren't 
able to get an EDU, because that that's just not allowed. But, 
having to type that long URL is a little much. 
Recommendations Examples of Participant Response(s) 
Users want a shorter, simpler 
URL. 
I didn't have any problem with it, but I can see that it would be 
better to have a little more user friendly name or, on the app, do 
you plan to make it part of My Health at Vanderbilt?  
Users want the website to be 
searchable online. 
Another thing, you know, if you go to under the medical center’s 
“Diabetes Map”, it will give you directions how to get to the 
diabetes center. 
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Error frequency and severity concerns and participant recommendations. Users 
voiced error-related usability concerns in focus groups more that any other sub-category. Error 
frequency and severity considers “how often users make errors while using a system, how 
serious the errors are, and how users recover from the error” (U.S. Department of Health and 
Human Services, 2014, para. 4). Although saturation of concerns for this usability sub-category 
was reached by the fourth focus group, at least one of five error-related concerns was reported in 
every single focus group session.  
Chronologically, the error-related problems reported by users were confronted very early 
in the user engagement process with Diabetes MAP. First, the highest reported usability issue 
across focus groups pertained to web browser compatibility issues and error messages faced 
prior to accessing the website. These errors surfaced, despite the fact that participants were given 
a handout with web browser requirements upon enrollment in the study (see Appendix E). Some 
users encountered overwhelming barriers to accessing the site due to the difficulty of creating an 
account and logging into their accounts. On occasion, users reported enlisting the help of 
personal and study-related technical support resources to recover from more severe errors and 
barriers to using the site.  
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Users wanted a simplified, streamlined process of getting acquainted and accessing 
Diabetes MAP. Acknowledging the prevalence of web browser-related issues, users called for 
web browser compatibility that encompasses multiple browsers, and that is more flexible and 
inclusive of older, more common versions of the web browsers. Table 9 reviews the error-related 
issues, and the recommendations for improvements offered by participants. 
Table 9. 
Participant Concerns and Recommendations Regarding of Error Frequency and Severity 
Issues Examples of Participant Response(s) 
Web browser compatibility 
issues/error messages 
I used Internet Explorer when I typed it all in, it kept going to a 
cannot-find-page error. And it did it three or four times … And 
then I just wiped everything again and tried it again. 
Error message/difficulty at 
login 
Just getting on it! It kept coming back with an error on the page. 
Difficulty searching /finding 
correct medication name 
Finally the one I was on came up, but they used the scientific name 
and a different amount and like… I just selected it because.   
Difficulty searching /finding 
correct medication 
name/dosage combination 
You list the medications it would bring up a whole bunch of them 
you know with scientific names along with the name you use and 
the same dose, but like 20 different and you don’t know which one 
you’re on. 
Required technical support to 
use website 
I just happened to know this computer guy who was coming in my 
room to do some other work and I asked him … I said “can you 
get this website up?” It took him a while, and this is all this man 
does is IT work. He had to go to tools, he did the pop up, there was 
that one thing that said remove the pop ups and once that was 
done, it was OK, but I fooled around for days on that, so that part 
is not good. 
Recommendations Examples of Participant Response(s) 
Users want a simplified, 
streamlined set-up process. 
Make it … I'm not saying, very easy, you know. But, if I am trying 
to log in information, I don't want to search for 30 minutes to go 
and do information for 20 seconds.   
Users want more flexibility 
regarding web browsers and 
settings 
I would probably use it more except I couldn’t use it at work 
because it wouldn’t work with my computer at work. And then I 
tried using it on my phone and my kindle and really couldn’t get it 
to work on that either.  I did have a new computer that I just 
bought at home. I could use it at home, but I was really limited 
because of that platform. 
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User subjective satisfaction concerns and participant recommendations. User 
subjective satisfaction concerns were reported in the lowest number of focus group sessions 
(n=2). User subjective satisfaction refers to the extent to which users like the website (U.S. 
Department of Health and Human Services, 2014). Users who did report dissatisfaction with 
either the website or its features cited the non-user-friendliness its user interface as the primary 
culprit. In these discussions, participants expressed overall frustration from exploring the 
website. Overall, participants wanted critical usability issues to be eliminated so that they 
optimally engage and receive the benefits of the website. Table 10 describes the participants’ 
concerns and recommendations regarding their satisfaction with the website. 
 
In focus groups, participants uncovered several critical usability issues regarding the 
Diabetes MAP website, endorsed the site’s design along some dimensions of usability, and 
offered detailed recommendations for how the site can be improved overall. Consistent across 
data collection methods were user concerns with how useful the Help materials embedded in the 
website for completing website related tasks, and thus achieving the optimal user experience. 
Table 10. 
Participant Concerns and Recommendations Regarding User Subjective Satisfaction  
Issues Examples of Participant Response(s) 
Non-user-friendly interface I'm not an IT person, but I'm a supervisor in my department, and 
I deal with about 15 employees, and many lives, so I do not have 
a problem for what I do so far. But this one over here, it was like 
going against brick wall, okay? It was not friendly whatsoever. 
 
Just a little note on it, if you haven't thought about suicide, this 
website would make you do so. 
Recommendations Participant Response(s) 
Eliminate usability problems that 
frustrate users and discourage 
them from using the website. 
***On average, users rated the usability of Diabetes MAP and 
its features moderately to favorably. 
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The usefulness of website Help materials was only moderately endorsed via the WUS, and then 
was cited as a concern in five of nine focus groups sessions. Usability survey items least 
endorsed by participants were related to the site’s navigability, helpfulness of Help materials, 
and error-making and recovery. 
The most prevalent theme across data collection methods was observed in user reports of 
the website’s error-related experiences. In the survey, making errors and recovering from them 
was the least endorsed usability dimension for the Diabetes MAP website. In focus groups, 
participants cited error-related issues more frequently across focus groups than any of the other 
six dimensions of usability. Participants described their frustration and annoyance due to 
encountering web browser and website errors and error messages.  
Survey data revealed favorable ratings for the site’s accessibility and clarity of help 
information that was available. These survey data aligned with the ease of learning dimension of 
usability. These favorable user survey ratings were parallel to user assessments of ease of 
learning the Diabetes MAP in focus group sessions. Only four specific usability issues were 
presented in focus group sessions. These four issues were cited 11 times across five focus group 
sessions, making ease of learning one of the least prevalent dimensions of usability concerns 
highlighted in focus groups. 
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CHAPTER 4 
 
DISCUSSION & CONCLUSION 
 
Discussion 
Usability evaluation methods are issue-focused and designed to assess the extent to which 
real-life users can easily, efficiently, and effectively perform web-related tasks in a system. User-
based, participatory usability evaluation of web-based applications center participants and their 
experiences with a website to gauge and elicit user conceptualizations of usability – related 
problems and solutions (Jaspers, 2009). In this study, with deployed mixed methodologies and 
multiple methods identify user-based challenges to using the Diabetes MAP site around six 
major dimensions of web usability. The users were real diabetes patients who provided 
descriptions of their actual experiences using the site and recommendations for improving it. 
In addition to highlighting major usability concerns with the design of Diabetes MAP, 
participants also offered positive remarks regarding the usability of some features. One 
participant reported using the “Forgot Password” feature, which facilitated the secure delivery of 
his user account information and allowed him to login. This positive experience reflected a user 
who encountered an error, but then efficiently and effectively recovered from it.  Another 
participant reported using the web browser requirement handout given to participants to make a 
decision regarding accessing Diabetes MAP via a desktop computer or mobile digital device. She 
described reading the user specifications, then choosing to access the site on a computer web 
browser, as recommended in the user requirements. Zang and Dran (2000) coined the term, 
“dissatisfier,” for factors that, when present, make a website functional and usable, and when 
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absent, dissatisfying. By contrast, a “satisfier” is a positive, motivating factor in web design that 
add value to a website by improving user satisfaction. In this study, participants provided 
feedback on both positive/motivating and dissatisfying/de-motivating elements of the usability of 
the Diabetes MAP website. 
Users also described multiple strategies for overcoming usability challenges and barriers 
to using Diabetes MAP. Some examples of participant approaches to troubleshooting included: 
1) entering incorrect information in order to proceed to other locations on the site, 2) creating 
web browser bookmarks, 3) employing alternative methods for locating the Diabetes MAP 
website, and 4) trial and error. Trial and error was a particularly salient approach to 
troubleshooting, as it was mentioned in four of nine focus group sessions. Users attempted and 
innovated new ways of engaging and navigating the website in order to explore the full reaches 
of its potential. This feedback underscores the importance of employing web user evaluation 
methods that reveal positive attributes of website design and usability and strategies employed 
by users, in addition to those that identify usability concerns within a system. 
One of the strengths of this study was the number of participants engaged and focus 
groups sessions held. Twenty-seven participants attended nine focus groups. This sample size 
exceeds the recommendations of user-based methods for evaluating usability, for which only as 
few as five participants are needed to identify 80% of major usability issues in a system 
(Nielson, 2000). In the current study, over 80% of the usability issues presented by participants 
were reported in the first two focus groups after only eight participants have participated in focus 
group sessions.  
Study Limitations 
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Limitations to this study include the reliance on user-based participatory usability 
evaluation methods to assess the usability of the website. Industry guidelines, heuristics and 
protocols have been developed and are utilized by usability experts who are trained specifically 
in human-computer interaction evaluation methodologies. Studies have shown both expert-
driven (i.e., heuristic analysis) and user-driven usability evaluation methods to be equally 
effective and efficient for addressing web usability problems (Tan, Liu, & Bishu, 2009). 
However, user-based usability evaluation, including methods that involve focus group elicitation, 
are effective approaches for understanding how users frame their most critical design issues for 
web-based interventions (Jaspers, 2009). In this study, we deployed this user-driven approach to 
understanding how patients, themselves, engage a diabetes health website. This approach 
provided a rich and in-depth understanding of participant-identified usability concerns for a web-
based health intervention for diabetes patients. 
This study also relies on retrospective self-reports of users’ experiences using the 
Diabetes MAP website. Other usability evaluation methods, such as think-aloud protocols, 
cognitive walk-throughs, and remote user testing facilitate real-time data collection of user 
interactions with a system (Nielsen, 1995). These methods are useful for understanding user 
engagement profiles, user experience contexts, how they each impact when and how users 
experience usability challenges, and the processes by which tasks are performed. The current 
study is focused, rather, on understanding the user thoughts and motivations regarding their 
perceptions of the usability of the Diabetes MAP intervention.  
While usable and effective online health tools are powerful media for quick and dynamic 
knowledge distribution and health care delivery, there are still yet challenges to providing 
equitable access of these resources to a broad population. In this study, a racially and ethnically 
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diverse study sample was recruited from an academic medical center in order to elicit feedback 
from patients from a variety of backgrounds. This effort stemmed from the knowledge of 
significant disparities that exist regarding access and use of Internet health information along 
dimensions of race, ethnicity, education and income levels. Still, the study sample (i.e., primarily 
non-Hispanic White, well educated, middle income, and privately insured) does not necessarily 
reflect the general demographics of patients with diabetes. Thus, this study has limited 
generalizability beyond a population with these characteristics. However, studies have shown 
that racial and ethnic health and healthcare disparities still remain after differences in income, 
access, and insurance status have been considered (Sarkar, et al., 2011). In particular, individuals 
with little to no access to the Internet encounter a barrier to Internet-delivered interventions and 
may not experience the benefits of using web-based resources (Gilmour, 2007). 
Conclusion 
Usability issues, such as difficulty navigating, understanding, and completing tasks are 
barriers to using and benefiting from Diabetes MAP. Inherent to usability evaluation, user testing 
and user-centered design is the principle of iterative evaluation, which segues into future 
directions for the study. Presented here is a mixed-methodological, multi-method evaluation and 
analysis of the usability of a web-based diabetes health intervention. However, usability testing 
and user-design necessitate an iterative testing-refinement process in order to design a product 
that best suits and serves targeted users. Another iteration of usability testing and evaluation 
should follow a period of refinement and revision of the Diabetes MAP intervention to ensure 
that the recommended changes do, in fact, result in improved ratings of usability (Bailey, 2005). 
Once deemed usable to patients for which the website was designed, the Diabetes MAP 
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intervention should be tested to see if it is, in fact, an effective disease management intervention 
that improves medication adherence and subsequent health outcomes for diabetes patients.  
This study, and its implications that inform how web-based interventions should be 
designed and tested, are both timely, especially as patients are more frequently accessing health 
information online and are increasingly being directed to web-based resources and tools for 
health care and services delivery. This has become so much of a priority for public health that the 
“use of health communication strategies and HIT to improve population health outcomes, health 
care quality, and to achieve health equity” is now a Healthy People 2020 goal (U.S. Department 
of Health and Human Services, 2014) 
The findings of this study underscore the importance of user testing and usability evaluation 
for the design of web-based health interventions and highlights the need for usability testing that 
not only centers the needs and values of users, but also engages them in the design process. 
Future studies should utilize appropriate usability evaluation methods, including user-driven 
approaches in order to ensure that subsequent effects of Internet-delivered interventions on 
health behaviors and outcomes can be attributed to the intervention and not usability errors. 
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APPENDIX 
Appendix A. Images of Webpages in Diabetes MAP 
 
 
Home page, user account creation, and login 
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“My Medications” page with print/email list, text reminders, and MHAV features  
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Learn about medications through the “About” feature on the “My Medications” page 
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Text message reminder set-up linked from the “My Medications” page  
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Medication checklist questionnaire 
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“My Tailored Tools” page with information, motivation, and skills-based content 
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Appendix B. Focus Group Protocol 
Part I: 
INTRODUCTION 
(4 minutes) 
 Thank you for agreeing to meet with us. I’m _____________ from the Center 
for Health Services Research at Vanderbilt University Medical Center. I also 
have my colleague ______________ present to take notes for us.  
 
 We are speaking with participants to get various impressions of the Diabetes 
MAP website, a site for diabetes patients to help them manage their 
medications. The study is being funded by the National Institute of Diabetes 
and Digestive and Kidney Diseases. 
 
 As researchers, we would like to talk with you about your user experience 
with the Diabetes MAP and gather any feedback that you may have. What we 
learn from today’s discussion will help us improve the website and 
understand how websites like Diabetes MAP impact the way patients manage 
their medications. 
 
 This is an open discussion, so there is no right or wrong answers to any of our 
questions. Everything discussed here today will be kept confidential, so 
please be open and honest with your comments. Also, you do not have to 
answer any question you do not feel comfortable with.  
 
 I would like begin with introductions. Let’s go around the room. Please say 
your name. Can we start with you, _______________? 
 
Part II: 
GROUND RULES 
(1 minute) 
 I’d like to discuss some ground rules for our discussion. First, we need to 
make sure that this is a safe place for each of you to share your thoughts and 
opinions about the topics we will discuss. It is important that each person’s 
opinion is respected, and that each person feels comfortable enough to offer a 
different point of view. The purpose of this group is to ensure that we hear 
from all of you, so please, respect others’ opinions and feel free to offer 
different ones.  
 
 Second, please leave enough time for other people to respond. We would like 
to hear from all of you. 
 
 Finally, if you have not offered an opinion on a topic, I may ask your opinion. 
If you would like to comment, please do so, but there is absolutely no 
pressure to. You can always tell me that your opinion has been said by others 
or that you don’t have anything to say at this point.  
 
 Finally, just some housekeeping issues: The bathrooms are located (indicate 
location). If you need to use the bathroom during our discussion, feel free to 
do so, but please be as quiet as possible when you open and close the door 
because we are recording everything. This session will take about 90 minutes. 
Please turn off your cell phones.  
 
 At this time I’m happy to answer any questions or concerns you have before 
we begin. 
 
Part III: Focus Group 
Questions 
 
OPENING 
(3 minutes) 
OPENING 
 
 How long have you had diabetes, and how long have you been taking 
medications? 
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TOPIC #1 
(8 minutes) 
Topic #1: Challenges with Diabetes MAP 
 
 What challenges did you encounter with the Diabetes MAP website? 
o Probe: What specific features were challenging? 
o Probe: What about the features was challenging? 
 
TOPIC #2 
(5 minutes) 
Topic #2: Most Favorite Aspects 
 
 What did you like the most about the Diabetes MAP website? 
o Probe: What about this component did you like? 
 
TOPIC #3 
(5 minutes) 
Topic #3: Least Favorite Aspects 
 
 What did you like least about the Diabetes MAP website? 
o Probe: What about this component did you not like? 
 
TOPIC #4 
(5 minutes) 
Topic #4: Specific Features of Diabetes MAP 
 
(demonstrate how to create an account) 
 What was your experience creating an account like? 
(demonstrate how to log in) 
 What was your experience logging in like? 
(demonstrate how to add medications) 
 What was your experience like adding medications in Diabetes MAP? 
(demonstrate how to view medication information) 
 What was your experience viewing medication information like? 
(demonstrate how to email a medication list, print a list, and how to view 
online patient portal) 
 What was your experience using these tools like? 
(demonstrate how to set up text message reminders) 
 What was your experience with the text message reminder system? 
(demonstrate how to view My Tailored Tools content) 
 What was your experience using My Tailored Tools? 
TOPIC #5 
(5 minutes) 
Topic #5: Benefits 
 
 What else about the Diabetes MAP website did you find valuable or helpful? 
o Probe: How useful did you find the website resources, like the Help 
videos and Diabetes MAP instruction sheet useful? 
o Probe: What do you think about the text message reminder 
function? Emailed medication list? Printed list? Link to online 
patient portal? 
o Probe: What do you think about the content in the “My Tailored 
Tools” section? 
 
TOPIC #6 
(5 minutes) 
Topic #6: Barriers to Using the Website 
 
 What barriers to using the website did you encounter in your daily life? 
 
TOPIC #7 
(7 minutes) 
Topic #7: Ideal Conditions 
 
 What conditions do you think are necessary for someone to have the best 
experience using the Diabetes MAP website? 
o Probe: How long do users need to use the site? 
o Probe: How many times do you think users need to be able to access 
the website? 
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o Probe: Who all should have access to the website? 
 
TOPIC #8 
(8 minutes) 
Topic #8: Modality Preference 
 
 Do you prefer using websites, like Diabetes MAP, to other ways of learning 
how to manage your medications? 
 
o Probe: Why or why not? 
o Probe: What other ways would you have liked to receive 
information on managing your diabetes medications? 
o Probe: What about that mode of delivery makes it your preference? 
 
TOPIC #9 
(8 minutes) 
 
Topic #9: Improvements 
 
 How can the Diabetes MAP website be improved? 
 
CLOSING 
(5 minutes) 
 Those were all the questions that we wanted to ask. Do you have any final 
thoughts about the Diabetes MAP website that you would like to share? 
 Thank you so much for your time. 
  
53 
Appendix C. 
Usability Concerns by Focus Group Session 
  Focus Group Number 
# Issue 1 2 3 4 5 6 7 8 9 
Total 
Count 
1 Error message/difficulty at login  X  X   X  X    X  X 6 
2 Complicated URL - not locatable  X  X   X      3 
3 Time zone locator difficult to use  X      X    2 
4 Difficulty searching for/finding correct medication name  X  X   X      3 
5 Difficulty searching for/finding correct medication dosage  X  X       X  3 
6 Progress not saved  X  X   X      3 
7 Tailoring mechanism unclear to users  X         1 
8 Directions within website unclear  X     X  X    3 
9 Help videos dysfunctional  X         1 
10 Help videos not useful for completing tasks/accessing features  X  X    X     3 
11 Confusion regarding purpose of site/features  X  X   X   X    4 
12 Placement/layout of functionality/content not intuitive  X      X   X  4 
13 Automatic logout problematic  X  X        2 
14 Web browser compatibility issues/error messages  X  X  X  X  X  X  X   7 
15 Non-user-friendly interface   X       X  2 
16 Instructions accessing/using the website unclear   X  X   X  X    4 
17 Navigation - scrolling required to access site features/tasks   X  X       X 3 
18 Page loading time too long   X   X   X    3 
19 Navigation - need to be able to navigate away from Help videos   X        1 
20 Issues navigating using buttons/navigation menu   X  X      X  3 
21 Unclear that background was actually Help videos    X       1 
22 Compatibility with other digital devices     X    X   2 
23 Required technical support to use website     X      1 
24 Difficulty scrolling using child windows         X  1 
 NUMBER OF ISSUES IN EACH FOCUS GROUP 14 15 5 9 5 7 2 6 2  
 NUMBER OF NEW ISSUES 14 6 1 2 0 0 0 1 0  
 NUMBER OF TOTAL ISSUES REPORTED TO DATE 14 20 21 23 23 23 23 24 24  
 PROPORTION OF TOTAL ISSUES REPORTED TO DATE 0.58 0.83 0.88 0.95 0.96 0.96 0.96 1 1  
 NUMBER OF PARTICIPANTS IN THIS FOCUS GROUP           
 NUMBER OF TOTAL PARTICIPANTS ENROLLED TO DATE           
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Appendix D. 
Usability Concerns by Sub-Category   
# Issue 
Usability 
Dimension 
Number of Focus 
Groups Issue is 
Reported 
Prevalence of 
Issues Reported by 
Usability 
Dimension 
16 Instructions accessing/using the website unclear Ease of learning 4 
11 
8 Directions within website unclear Ease of learning 3 
10 Help videos not useful for completing tasks/accessing features Ease of learning 3 
9 Help videos dysfunctional Ease of learning 1 
6 Progress not saved Efficiency 3 
13 
18 Page loading time too long Efficiency 3 
3 Time zone locator difficult to use Efficiency 2 
13 Automatic logout problematic Efficiency 2 
22 Compatibility with other digital devices Efficiency 2 
24 Difficulty scrolling using child windows Efficiency 1 
14 Web browser compatibility issues/error messages Errors 7 
20 
1 Error message/difficulty at login Errors 6 
4 Difficulty searching/finding correct medication name Errors 3 
5 Difficulty searching/finding correct medication name/dosage combination Errors 3 
23 Required technical support to use website Errors 1 
12 Placement/layout of functionality/content not intuitive Intuitive design 4 
13 
17 Navigation - scrolling required to access site features/tasks Intuitive design 3 
20 Issues navigating using buttons/navigation menu Intuitive design 3 
7 Tailoring mechanism unclear to users Intuitive design 1 
19 Navigation - need to be able to navigate away from Help videos Intuitive design 1 
21 Unclear that background was actually Help videos Intuitive design 1 
11 Confusion regarding purpose of site/features Memorability 4 
7 
2 Complicated URL - not locatable Memorability 3 
15 Non-user-friendly interface 
User subjective 
satisfaction 
2 
2 
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Appendix E. Diabetes MAP Instructions for Participants 
Welcome to  
DIABETES MAP 
 
 Diabetes MAP is a website for patients with diabetes that is designed to 
help patients take their medications.  
 
 To get started with the website, you will need to create a user account. 
After logging in, you will be asked to enter information pertaining to your 
medications. You will then be asked a series of questions regarding your 
medications.  
 
 After completing these questions, you will be directed to a series of 
modules that are tailored to your specific needs pertaining to taking your 
diabetes medications. 
 
 The following are some of the other features included on the website: 
o Help Videos with tips on how to use the website 
o Helpful information specific to your medications 
o Capability to print your medication list or have it sent to 
your email box 
o Ability to set up text message reminders 
o A quick link to the online patient portal 
o Individually-tailored tools to with informational, 
motivational, and skill-building tips 
 
 You may explore to Diabetes MAP anytime and as long as you would like 
according to you specific needs. 
 
 You will be compensated $8 per hour of use of Diabetes MAP, up to ten 
(10) paid hours. 
 
Happy exploring! 
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Appendix F. Diabetes MAP Web Browser Requirements for Participants 
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